Related Experiment Video
Updated: Dec 1, 2025

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Reactive oxygen species in immune cells: A new antitumor target
Ling Wang1, Zheng Kuang2, Duo Zhang3
1Department of Stem Cells and Regenerative Medicine, Center for Translational Medicine, Naval Medical University, Shanghai 200433, PR China.
Abstract:
Immune cells have the potential to control the growth of tumor. However, this effect could be offset by immunosuppression associated with an increased production of reactive oxygen species. Multiple studies indicate that the antitumor effect of immune cells is correlated with their antioxidant capacity. This review discusses the role of reactive oxygen species in the tumor microenvironment by describing their distinct effects on different immune cells, including myeloid-derived suppressor cells, regulatory T cells, tumor-associated macrophages, cytotoxic T lymphocytes, natural killer cells, and dendritic cells. In the end, we conclude with the prospect of treatment for cancer by targeting antioxidant defense in immune cells.
Insights
Reactive oxygen species can suppress anti-tumor immune responses. Enhancing immune cell antioxidant capacity may improve cancer immunotherapy by targeting the tumor microenvironment.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Immune cells play a crucial role in controlling tumor growth.
- Tumor growth can be promoted by immunosuppression linked to reactive oxygen species (ROS).
- The antitumor efficacy of immune cells correlates with their antioxidant capacity.
Purpose of the Study:
- To review the multifaceted role of ROS in the tumor microenvironment.
- To elucidate the distinct effects of ROS on various immune cell populations.
- To explore the potential of targeting antioxidant defenses for cancer treatment.
Main Methods:
- Literature review of studies on ROS and immune cells in cancer.
- Analysis of the impact of ROS on myeloid-derived suppressor cells, regulatory T cells, tumor-associated macrophages, cytotoxic T lymphocytes, natural killer cells, and dendritic cells.
- Synthesis of findings regarding the relationship between antioxidant capacity and immune cell function.
Main Results:
- ROS exhibit differential effects on various immune cells within the tumor microenvironment.
- Increased ROS production often leads to immunosuppression, hindering anti-tumor responses.
- Immune cells with higher antioxidant capacity demonstrate greater efficacy against tumors.
Conclusions:
- The balance of ROS is critical in modulating immune responses within the tumor microenvironment.
- Targeting antioxidant defense mechanisms in immune cells presents a promising therapeutic strategy for cancer.
- Future cancer treatments may involve enhancing the antioxidant capacity of immune cells to bolster anti-tumor immunity.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Oxygen Requirements and Growth Patterns

